Skip to main content
Premium Trial:

Request an Annual Quote

N-of-One, Appistry Sign Sequence Informatics Co-Marketing Agreement

NEW YORK (GenomeWeb News) – N-of-One and Appistry said today that they have signed an agreement to jointly provide genetic sequence data analysis and molecular interpretation services.

Specifically, both companies will market N-of-One’s interpretation services and content together with Appistry’s bioinformatics next-generation sequencing analysis solutions and services. Bringing their offerings together will provide a complete workflow that will support diagnostic labs, healthcare providers, and other healthcare organizations, they said.

"The challenges and capabilities needed to realize the promise of precision medicine are very complex, which has meant that genomics-based approaches are limited to those willing and able to make major investments in infrastructure and expertise," Kevin Haar, Appistry's president and CEO, said in a statement. "By working together with N-of-One, we will make these critical services available to any clinician."

The combined solution will provide "high-quality, high-value analytics and molecular profiling to the point of care, enabling oncologists and treating clinicians to most efficiently and effectively gain state-of-the-art knowledge and insights into possible treatment therapies specific to each patient," Chris Cournoyer, N-of-One's CEO, added.

Terms of the agreement were not disclosed.